Skip to main content
. 2022 Feb 18;10(2):327. doi: 10.3390/vaccines10020327

Table 4.

Clinical and laboratory factors and their associated risk for negative humoral responses.

Variable No SARS-CoV-2 IgG
24 Weeks after 1st Vac
No Neutralizing Antibodies
24 Weeks after 1st Vac
Adjusted Odds Ratio (95% CI); Significance Adjusted Odds Ratio (95% CI); Significance
Age per 1 year 1.056 (0.962–1.160); p = 0.249 1.026 (0.960–1.096); p = 0.450
CRP per 1 mg/dL 1.017 (0.952–1.087); p = 0.617 1.127 (0.948–1.341); p = 0.176
Serum albumin per 0,1 g/dL 0.965 (0.937–0.994); p = 0.017 0.988 (0.963–1.014); p = 0.356
Vitamin D per 1 ng/mL 0.912 (0.816–1.019); p = 0.105 0.963 (0.893–1.039); p = 0.334
Positive hepatitis B vac response 0.514 (0.061–4.338); p = 0.541 0.263 (0.057–1.201); p = 0.085
Hemoglobin per 1 g/L 1.217 (0.513–2.888); p = 0.656 0.732 (0.364–1.471); p = 0.381
Diabetes mellitus 1.517 (0.280–8.207); p = 0.629 0.467 (0.107–2.034); p = 0.311

SARS-CoV-2 IgG = Severe Acute Respiratory Syndrome-Corona Virus type-2 Immunoglobulin G; vac = vaccination; CRP = C-reactive protein.